Table 1 Association between PSPC1 status and clinicopathological parameters in 114 breast cancer.

From: PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2

Status

PSPC1 status

P value

Weak (n = 84)

Strong (n = 30)

Age (year)a

53.4 ± 10.0

51.4 ± 13.6

0.39

Body weight (kg)a

55.0 ± 8.9

52.3 ± 5.7

0.12

BMIa

21.9 ± 3.2

21.8 ± 3.7

0.85

Stage

I

48

10

 

II

32

18

 

III

4

2

0.080

Pathological T factor (pT)

pT1

56

16

 

pT2–4

28

14

0.19

Pathological N factor (pN)

pN0–1

67

20

 

pN2–3

17

10

0.15

Histological grade

1–2

75

24

 

3

9

6

0.20

Lymphovascular infiltration (LVI)

Negative

50

13

 

Positive

34

17

0.34

ER labeling index (%)a

68.6 ± 26.1

72.9 ± 24.2

0.43

PR status

Negative

12

6

 

Positive

72

24

0.46

HER2 status

Negative

76

25

 

Positive

8

5

0.29

PSF status

Weak

46

11

 

Strong

38

19

0.089

  1. 0.05 ≤ P value < 0.10 was considered borderline significant, and is listed in italics.
  2. aData are presented as mean ± SD. All other values represent the number of cases.
Back to article page